Long-term immunological changes in azathioprine-treated MS patients

E. Corsini, L. La Mantia, M. Gelati, A. Dufour, C. Milanese, G. Massa, A. Nespolo, A. Salmaggi

Research output: Contribution to journalArticlepeer-review


The long-term immunological effects of azathioprine treatment have been investigated in 8 multiple sclerosis patients with different course of disease, chronic progressive (CP) or relapsing progressive (RP). We studied fluctuations in peripheral blood mononuclear cell subsets, IgG, IgM and soluble vascular cell adhesion molecule-1 (sVCAM-1), before and after 2 (T24) and 3 (T36) years of therapy. We observed a significant decrease in CD8+ cells over time and a trend to lower percentage of CD3-CD56+ cells at T24 and T36. CD4+CD45RA+ cells in MS patients were lower than in healthy controls before therapy and reached values similar to those of healthy controls at T24 and T36. The remaining immunological parameters did not show any significant fluctuations.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalNeurological Sciences
Issue number2
Publication statusPublished - 2000


  • Azathioprine
  • Multiple sclerosis
  • PBMNC subsets
  • sVCAM-1

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology


Dive into the research topics of 'Long-term immunological changes in azathioprine-treated MS patients'. Together they form a unique fingerprint.

Cite this